Caxton Associates LP Fulgent Genetics, Inc. Transaction History
Caxton Associates LP
- $3.12 Billion
- Q4 2024
A detailed history of Caxton Associates LP transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Caxton Associates LP holds 39,934 shares of FLGT stock, worth $674,485. This represents 0.02% of its overall portfolio holdings.
Number of Shares
39,934
Previous 11,432
249.32%
Holding current value
$674,485
Previous $248,000
197.18%
% of portfolio
0.02%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding FLGT
# of Institutions
208Shares Held
17.1MCall Options Held
2.36MPut Options Held
47.9K-
Black Rock Inc. New York, NY3.92MShares$66.2 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.53MShares$25.9 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.39MShares$23.5 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.05MShares$17.7 Million0.0% of portfolio
-
State Street Corp Boston, MA819KShares$13.8 Million0.0% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $511M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...